University System of Maryland

State Grid Corporation of China

North China Electric Power University

State Grid Liaoning Electric Power Company Limited Economic Research Institute

Ming Meng

Yan Liu

Silvia Muro Galindo

Yingwei Song

Jian Liu

Dalong Hu

Liaoyi Ning

Xiping Wang

Li Jiang

Carmen Garnacho Montero

A renewable energy-based hybrid bi-directionally interactive DC traction power supply system includes two traction substations. Each substation includes transformers, rectifiers, bidirectional AC-DC converters, a DC bus, a catenary, a steel rail and a section post. A DC bus between two adjacent traction substations is provided with a DC renewable energy system constructed by an electric vehicle charging-discharging system, a distributed generation and more than one low voltage DC microgrid. The DC renewable energy system is connected to the DC bus between two adjacent traction substations through a high voltage DC bus, thus a DC circular microgrid being formed in a power supply section post. The electric vehicle charging-discharging system is formed by more than one bidirectional DC-DC charging-discharging equipments which are intended for in connection with the power batteries of the electric vehicle. The renewable energy-based hybrid bi-directionally interactive DC traction power supply system of the invention realizes effective usage of distributed generation and recycling of electric locomotive braking energy, reducing DC voltage fluctuation, thus improving reliability of the DC traction power supply system.

Renewable energy-based hybrid bi-directionally interactive DC traction power supply system

A system for targeted delivery of agents (e.g., molecular probes, diagnostic agents, therapeutic agents, imaging agents, research or analytical compounds, enzymes, peptides, proteins, lipids, lipoproteins, sugars, hormones, vitamins, nucleic acids, viruses, bacteria, and/or cells) including use of a composition containing the agent and a targeting moiety, specific for a determinant at the target location. An exemplary composition of the system includes a targeting moiety of one of peptides &#x3b3;3, 2&#x3b3;3, 3&#x3b3;3, A1, B7, B8, B9, B1O, and D6, specific for targeting ICAM-I. The system enables effective, versatile, and safe targeting and transport of agents. The system is useful in research applications, as well as in the context of translational science and clinical interventions.

Peptides for transport of therapeutics and their carriers in mouse models and humans

Growing community of inventors

Baoding, China

Ming Meng